Blau

CONTENTS
DiePharmazie 2/2018

 

Original articles

Al-Gousous J, Langguth P: A time-scaled convolution approach to construct IVIVC for enteric-coated acetylsalicylic acid tablets
doi: 10.1691/ph.2018.7136 (pp. 67-69)

 

Cunchun Dai, Shaoqi Qu, Ruili Zhang, Li Zhao, Yuwen Li, Jiajia Zhu, Chunmei Wang, Hui Guo, Zhihui Hao: Development and analytical characterization of a new antiparasitic fenbendazole compound tablet and pharmacokinetic investigations after its oral administration to dogs
doi: 10.1691/ph.2018.7123 (pp. 70-75)

 

Hagesaether E: Altered drug release from Orfiril® long following ethanol consumption – extent and consequences
doi: 10.1691/ph.2018.7096 (pp. 76-79)

 

Weihong Zhu, Xinzhan Mao, Wanchun Wang, You Chen, Ding Li, Hui Li, Pengcheng Dou: Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells
doi: 10.1691/ph.2018.7836 (pp. 80-86)

 

Jiang ZM, Qiu HB, Wang SQ, Guo J, Yang ZW, Zhou SB: Ganoderic acid A potentiates the antioxidant effect and protection of mitochondrial membranes and reduces the apoptosis rate in primary hippocampal neurons in magnesium free medium
doi: 10.1691/ph.2018.7108 (pp. 87-91)

 

Deqing Sun, Aiying Xue, Xia Xue, Manru Ren, Jing Wu, Rongmei Wang: Acetylpuerarin protects against OGD-induced cell injury in BV2 microglia by inhibiting HMGB1 release
doi: 10.1691/ph.2018.7819 (pp. 92-97)

 

Fan-Fang Tie, Guang-Xiang Luan, Wen-Na Zhou, Zhen-Hua Wang, Xiao-Bing Shi, Gang Li, Hong-Lun Wang: Effects of the oligostilbenes from Iris lactea Pall. var. chinensis (Fisch.) Koidz on the adipocytes differentiation of 3T3-L1 cells
doi: 10.1691/ph.2018.7844 (pp. 98-103)

 

Kawami M, Yamada Y, Issarachot O, Junyaprasert VB, Yumoto R, Takano M: P-gp modulating effect of Azadirachta indica extract in multidrug-resistant cancer cell lines
doi: 10.1691/ph.2018.7116 (pp. 104-109)

 

Todo M, Ueda S, Osaki A, Sugitani I, Takahashi T, Takahashi M, Makabe H, Saeki T, Itoh Y: Improvement of treatment outcomes after implementation of comprehensive pharmaceutical care in breast cancer patients receiving everolimus and exemestane
doi: 10.1691/ph.2018.7837 (pp. 110-114)

 

Kimura M, Wai M, Usami E, Teramachi H, Yoshimura T: Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy
doi: 10.1691/ph.2018.7832 (pp. 115-119)


Zurück